Trends and results of carotid artery surgery in Germany

Size: px
Start display at page:

Download "Trends and results of carotid artery surgery in Germany"

Transcription

1 English version of Trends und Ergebnisse der Karotischirurgie in Deutschland Teil 1: klinische Stadien, perioperative Morbidität und Letalität sowie Bewertung der Qualitätsindikatoren Gefässchirurgie : ] DOI /s Springer-Verlag Berlin Heidelberg 2013 L. Deutsch 1 B. Haller 2 H. Söllner 1 M. Storck 3, 4 H.-H. Eckstein 1 1 Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie, Klinikum Rechts der Isar, Technische Universität München, Munich 2 Institut für Medizinische Statistik und Epidemiologie, Technische Universität München, Munich 3 Klinik für Gefäß- und Thoraxchirurgie, Städtisches Klinikum Karlsruhe 4 Kommission für Qualität und Sicherheit, Deutsche Gesellschaft für Gefäßchirurgie und Gefäßmedizin (DGG) Trends and results of carotid artery surgery in Germany Part 1: clinical stages, perioperative morbidity and mortality and assessment of quality indicators Aim Despite substantial progress in the acute treatment of cerebral ischemia, stroke is still the second most common cause of death worldwide and the leading cause of long-term disability [15]. Between 20 and 30% of all cerebral ischemia is caused by stenosis of the internal carotid artery. In a meta-analysis, the prevalence of moderate carotid stenosis ( 50%) in people younger than 70 years was reported to be 4.8% for men and 2.2% for women. In persons who were 70 years, the prevalence was higher for both sexes at 12.5% for men and 6.9% for women [5]. The prevalence for highgrade carotid stenosis 70 was between 0 and 4.9% [5, 11]. Especially dangerous are unstable plaque stenoses, which significantly increase the risk of cerebral embolism [8, 12]. Although it has been shown in recent studies that plaque composition represents an important factor in the assessment of stroke probability [2], the following applies: D The degree of stenosis is the only indication criterion with the highest level of evidence for carotid endarterectomy. The recently published S3 guidelines for extracranial carotid stenosis and other national and international guidelines recommend considering carotid endarterectomy (CEA, [6, 10, 13, 14]) in patients with 60 99% asymptomatic carotid stenosis, because this significantly reduces their risk for stroke. A benefit of CEA in patients with asymptomatic carotid stenosis can only be achieved, if the complication rate is <3% [7]. For symptomatic carotid stenosis, CEA is the method of choice. In patients with 70 99% stenosis after a transient ischemic attack (TIA) or nondisabling stroke, CEA is recommended and should also be considered in patients with symptomatic stenosis of 50 69%. For stenoses <50%, CEA is not recommended [7]. Since 2002, all German hospitals are required to participate in the mandatory, external quality assurance (QA) registry for the reconstruction of carotid arteries. The federal office Quality Assurance ( Bundesgeschäftsstelle Qualitätssicherung ggmbh, BQS) was responsible for the registry until 2008 and since 2009 the Institute for Applied Quality Improvement and Research in Health Care ( Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, AQUA Institute), a professionally independent institution in accordance with 137a of the fifth book of the German social code book (SGB V) is responsible for the registry. The national reports contain data on all of the quality indices (QI) and various additional descriptive analyses (basic evaluation). At the time that the QA process was introduced, care deficits were suspected particularly in relation to the indication for surgery and related complications. Documentation for QA therefore focuses on the important cornerstones of the correct indications for carotid artery stenosis as well as periprocedural strokes and deaths. Thus, QI were defined and are shown in. Tab. 1. For the present study, the period from 2003 was used, because the 2002 report with approximately 15,000 documented CEA was still incomplete. The goal was to determine possible changes in the patient population, the surgical methods, and clinical results using the 9-year period. In part 1 of the article, changes in the patient population, the clinical stages (inclu ding Gefässchirurgie

2 Tab. 1 Definitions of the quality indices (QI) of the national quality assurance Carotid artery reconstruction used in this study Definition of the indicator Indication QI1 Stenosis grade 60% in asymptomatic carotid stenosis ( 85%) QI2 Stenosis grade 50% in symptomatic carotid stenosis ( 95%) Perioperative stroke or death QI3 In asymptomatic carotid stenosis I (without contralateral stenosis or >70% stenosis) QI4 In asymptomatic carotid stenosis II (with contralateral stenosis or >70% stenosis) QI5 In asymptomatic carotid stenosis I ( 70% stenosis) QI6 In asymptomatic carotid stenosis II (50 69% stenosis) QI8 Severe stroke or death (Rankin score: 4 6) Tab. 2 Modified Rankin scale for classification of the disability severity after a stroke Severity of the neurological disability Rankin 0 No neurological disability Rankin 1 No significant functional neurological disability Rankin 2 Slight functional disability Rankin 3 Moderately severe disability but can walk unassisted and/or moderately severe aphasia Rankin 4 Severe disability, walking only with assistance Rankin 5 Invalidating disability, patient bedridden or wheel chair dependent Rankin 6 Dead indications) and periprocedural morbidity and mortality are presented. In the upcoming part 2, trends concerning the perioperative diagnostics and treatment procedures are presented in detail. Patients and methods The annual reports from of the QA registry of the BQS and the AQUA institute were systematically evaluated. Patient-related parameters (e.g., age, sex, indication, and symptoms) were documented. The indication groups are listed in. Infobox 1. In particular, the predefined QI were statistically analyzed to assess the indications and perioperative complication rates. Changes in the patient population and in the treatment methods as well as trends in the perioperative morbidity and mortality in the individual groups of indications were examined. Carotid artery stenting (CAS) has only been part of carotid artery stenosis QA since 2012; thus, no evaluation could be made regarding this. Concerning the individual quality indicators, it is important to note that in contrast to the basic evaluation they may focus only on a selected part of the population. Logistic regression analysis was used in the risk-adjusted QI perioperative stroke or death (QI7 and QI8). QI7 (perioperative stroke or death-adjusted risk using logistic carotid artery score I) was not included in the evaluation, because no individual data were available and it did not seem likely that a statistically meaningful trend could be calculated. A detailed description of the QI, including the current calculation rules, is available in German at under Themen/Leistungsbereiche. The Rankin classification used for QI8 is shown in. Tab. 2. To improve comparability of cases, patients with aortic dissection and procedures where a transposition of the caro tid/ subclavian artery was performed were excluded starting in 2010 because the carotid artery was not the target organ. The cases excluded as reported in the 2010 national assessment were also excluded retrospectively from the 2009 results. The statistical evaluation was performed using Software R Version (R Foundation for Statistical Computing, Vienna, Austria) and SPSS Version Changes in the frequency distribution of binary variables over time were evaluated using the Cochran Armitage trend test. To assess the change in the median time between the last event and surgery during the observation period, the Pearson correlation coefficient was used. A 2-sided significance level of α=5% was selected for all tests performed. Results Patients From , 229,304 carotid endarterectomy procedures were documented. During the observation period, the median number of the participating hospitals was 520/year; the median number of documented cases was 25,858/year. The patient-related data and the distribution of indications for carotid endarterectomy over the investigated period are summarized in. Tab. 3. The mean patient age increased from 69 to 71 years from 2003 to In the years thereafter, the median and mean patient age were not determined.» The proportion of patients older than 80 years increased significantly in the period examined In the study period, the proportion of patients who were 80 years or older at the time of surgery increased significantly from 10.8 to 16.9% (p<0.001,. Fig. 1). The proportion of women was on average 32% and did not change significantly over the survey period. The proportion of patients with status 3 in the classification of the American Society of Anesthesiologists (ASA) rose from 60.4 to 69.5% (p<0.001), while the group of patients with high comorbidity (ASA status 4 5) remained constant. Indications The QI1 (proportion of patients with asymptomatic carotid stenosis 60%) and QI2 (proportion of patients with 50% symptomatic carotid stenosis) met the quality targets of 85% (QI1) and 90% (QI2), respectively, throughout the study period (. Fig. 2). The distribution of the indication groups also changed over the survey period. The proportion of asymptomatic patients (group A) increased significantly compared to the symptomatic patients (group B) and carotid endarterectomy under special conditions (group C) from 50.7 to 53.1% (. Tab. 3;. Fig. 3a c). In the 2 Gefässchirurgie

3 Abstract Zusammenfassung Gefässchirurgie : DOI /s Springer-Verlag Berlin Heidelberg 2013 L. Deutsch B. Haller H. Söllner M. Storck H.-H. Eckstein Trends and results of carotid artery surgery in Germany Part 1: clinical stages, perioperative morbidity and mortality and assessment of quality indicators Abstract Background. Since 2002 all German hospitals are required to participate in the mandatory quality assurance registry for reconstruction of extracranial carotid arteries. Aim. This article documents the changes in the patient population, the clinical stages and clinical results from 2003 to The analysis of preoperative diagnostics, operative methods and procedural management will be dealt with in part 2 of this publication. Material and methods. The annual quality assurance reports of the registry (BQS, AQUA Institute) from 2003 to 2011 were evaluated. Patient characteristics as well as predefined quality indices (QI) and perioperative morbidity and mortality were statistically analyzed. Results. A total of 229,304 carotid endarterectomies were reported (male 68%, female 32%). The proportion of patients >80 years increased significantly throughout the years (p<0.001). The mean rates of asymptomatic and symptomatic stenoses as well as operations under special conditions (Indication group C) were 53%, 34% and 13%, respectively. The QI1 (proportion of patients with 60% asymptomatic carotid stenosis) and QI2 (proportion of patients with 50% symptomatic carotid stenosis) met the quality targets of 85% (QI1) and 90% (QI2), respectively, throughout the time period evaluated. The rate of perioperative stroke or death in patients with asymptomatic stenosis was reduced from 2.0% in 2003 to 1.1% (without contralateral stenosis 70%) and from 2.9% to 2.1% (with contralateral stenosis 70%) and in symptomatic patients from 4.0% to 2.7% (stenosis 70%, p<0.001) and from 4.6% to 2.3% (50 69% stenosis, p<0.001). The median overall mortality was 0.9%. In symptomatic carotid stenosis there was a significant reduction in the interval between the neurological index event to the operation from 25 to 9 days (p<0.001, R= 0.97). Conclusion. Since the implementation of the mandatory national quality assurance system for operative carotid artery reconstruction a progressive decrease of perioperative morbidity could be shown. The interval between neurological index event and operation decreased significantly throughout the survey period and averaged 9 days in Keywords Carotid stenosis Carotid endarterectomy Vascular surgical procedures Stroke Quality assurance Trends und Ergebnisse der Karotischirurgie in Deutschland Teil 1: klinische Stadien, perioperative Morbidität und Letalität sowie Bewertung der Qualitätsindikatoren Zusammenfassung Hintergrund. Seit 2002 besteht für alle deutschen Krankenhäuser die Verpflichtung zur Teilnahme an der Qualitätssicherung (QS) für die operative extrakranielle Karotisrekonstruktion. Ziel der Arbeit. Veränderungen der Patientenpopulation, der klinischen Stadien und der klinischen Ergebnisse von sollten ermittelt werden. Die Analyse der präoperativen Diagnostik, der Operationsmethoden und des prozeduralen Managements folgt in einer späteren Publikation. Material und Methoden. Die Jahresberichte des QS-Registers wurden systematisch ausgewertet. Patientenbezogene Parameter und prädefinierte Qualitätsindikatoren wurden statistisch evaluiert (Cochran- Armitage-Trend-Test, Korrelationskoeffizient nach Pearson, 2-seitiges Signifikanzniveau von α=5%). Ergebnisse. Es wurden operative Karotisrekonstruktionen (männliche/weibliche Patienten 68/32%) dokumentiert. Der Anteil an über 80-jährigen Patienten stieg signifikant an (p<0,001). Die Anteile an asymptomatischen und symptomatischen Stenosen betrugen 53 resp. 34% ohne signifikante Veränderungen. Es erfolgten 13% der Karotisoperationen unter besonderen Bedingungen (Rezidiv-, Simultaneingriffe, Aneurysma). Der Anteil der Patienten mit einem Stenosegrad 60% bei asymptomatischer und 50% bei symptomatischer Stenose lag stets im Qualitätszielbereich von 85 resp. 90%. Die Rate an perioperativen Schlaganfällen/Tod bei Patienten mit asymptomatischer Stenose verringerte sich von 2,0% in 2003 auf 1,1% (ohne kontralaterale Stenose 70%) bzw. von 2,9% auf 2,1% (mit kontralateraler Stenose 70%) und bei symptomatischen Patienten von 4,0 auf 2,7% (Stenose 70%, p<0,001) resp. von 4,6 auf 2,3% (50- bis 69%ige Stenose, p<0,001). Die mediane perioperative Letalität blieb bei 0,9%. Bei symptomatischen Patienten zeigte sich eine signifikante Reduktion des Intervalls zwischen neurologischem Indikatorereignis und Operation von 25 auf 9 Tage (p<0,001). Schlussfolgerungen. Seit 2003 hat der Anteil der über 80-jährigen Patienten deutlich zugenommen. Gleichzeitig kam es zu einer schrittweisen Senkung der perioperativen Komplikationsraten. Das Intervall zwischen neurologischem Indikatorereignis und Operation konnte hochsignifikant auf zuletzt nur noch 9 Tage verkürzt werden. Schlüsselwörter Karotisstenose Karotisendarteriektomie Vaskuläre Operationsmethoden Schlaganfall Qualitätssicherung group of patients with symptomatic carotid stenosis, the proportion of patients with amaurosis fugax and TIA decreased significantly from 21.5 to 18.1% and from 45.5 to 36.1%, respectively (p<0.001). The group of patients with a previous stroke (Rankin score) increased significantly from 34.9 to 40.5% (. Tab. 3). In symptomatic carotid stenosis, a significant reduction in the interval between the neurological event and surgery from 25 to 9 days was observed (p<0.001, R= 0.97;. Fig. 4).» Interval between neurological event and surgery decreased from 25 to 9 days The emergency carotid endarterectomy rate rose significantly from 1.7 to 3.6% Gefässchirurgie

4 Infobox 1 Indication groups Indication group A: asymptomatic carotid artery stenosis Event free within the last 6 months (no new-onset focal neurological deficits in the ipsilateral region, not meant are aspects related to previous events) excluding carotid endarterectomy under special circumstances (Indication group C) Indication group B: symptomatic carotid artery stenosis, elective Relative frequency ,340 23,499 25,629 25,570 26,087 26,961 27,546 27,170 27,484 =n 10.9% 12.1% 12.8% 13.6% 14.8% 14.7% 15.3% 16.6% 16.9% 38.8% 39.9% 40.0% 40.6% 40.9% 40.6% 42.1% 43.1% 43.9% 36.3% 34.9% 34.7% 32.4% 31.3% 31.8% 29.6% 27.6% 26.5% Ipsilateral with: F amaurosis fugax F hemispheric TIA or F stroke within the last 6 months excluding carotid endarterectomy under special circumstances (Indication group C) Indication group C: carotid endarterectomy under special circumstances % % 12.5% 13.5% % 12.9% 13.0% 12.7% 12.7% years years years <60 years Fig. 1 8 Distribution of age groups over the observation period. Cochran Armitage trend test, p<0.001 F increasing TIA F acute, progressive stroke F aneurysm F coiling F combined carotid artery coronary surgery or combined carotid artery vascular surgery F certain plaque morphology characteristics with <50% stenosis (NASCET) for symptomatic carotid stenosis F transient lesions F relapse Relative freequency % 88.9% 98.7% 97.6% TIA transient ischemic attack, degree of stenosis based on NASCET ultrasound criteria for analysis of carotid artery stenosis from the North American Symptomatic Carotid Endarterectomy Trial. (p<0.001). Within this group, the proportion of patients with crescendo TIA decreased from 48.9 to 43.4% over the study period, while the proportion of patients with acute or progressive stroke rose from 35.6 to 56.1% (p<0.001;. Tab. 3). Perioperative morbidity and mortality The rate of perioperative stroke or death in patients with asymptomatic stenosis without contralateral stenosis (QI3) continuously decreased significantly from 2.0% in 2003 to 1.0% in The rate of perioperative stroke or death in patients with asymptomatic stenosis with contralateral stenosis (QI4) was on average 2.5% and did not change significantly over the survey period (. Fig. 5). For patients Year QI1 ( 60% asymptomatic carotid artery) QI2 ( 50% symptomatic carotid artery stenosis) Fig. 2 8 Percent (%) of patients with asymptomatic stenosis 60%, quality indicator 1 (QI1, red), and symptomatic stenosis 50%, quality indicator 2 (QI2, blue), target: QI1: 85%; QI2: 90% with symptomatic stenosis 70% (QI5), perioperative stroke or death decreased from 4.0 to 2.7% (p<0.001) and for patients with symptomatic stenosis of 50 69% (QI6), the rate decreased from 4.6 to 2.3% (p<0.001;. Fig. 6). The average overall morbidity in the form of severe stroke (Rankin score 4, 5) or death (QI8, 4 Gefässchirurgie

5 Tab. 3 Overview of the clinical data distribution Total p n % n % n % n % n % n % n % n % n % n % Age (years) < , < , , , , , , , , , > , Sex m 13, , , , , , , , , , f , ASA < , , , , , , , , , , , Indication group Symptoms (from B) A , , , , , , , , , <0.001 B , C , Amaurosis , <0.001 fugax Ipsilateral , hemispheric TIA Stroke with , Rankin 0 5 Other Emergency Total <0.001 Crescendo TIA Acute/ progressive stroke Other ASA 1 5 Classification of patients by the American Society of Anesthesiology into groups based on their physical condition, f female, m male, TIA transient ischemic attack. Gefässchirurgie

6 Tab. 4 Overview of complications Local complications Bleeding requiring reoperation Periferal nerve lesion Carotid artery occlusion Total p n % n % n % n % n % n % n % n % n % n % < General complications requiring treatment Total <0.001 DVT Pul mo- nary Cardiovascular <0.001 DVT Deep vein thrombosis.. Fig. 7) was 1.5%, but also significantly decreased from 1.7% in 2003 to 1.2% in 2011 (p<0.001). The average overall mortality of 0.9% remained constant over the survey period. Other perioperative complications A reduction was observed for all local complications (e.g., postoperative bleeding requiring surgery, peripheral nerve injury, and carotid artery occlusion). This is most obvious for peripheral nerve lesions (from 1.9 to 1.4%, p<0.001). The rate of general complications requiring treatment also decreased (from 3.9 to 3.7%, p<0.001). However, this is due to a decrease in the rate of cardiovascular complications (from 1.8 to 1.2%), since the rate of pulmonary complications and deep vein thrombosis (DVT) did not change over the survey period (. Tab. 4). Discussion Interpretation of results The present nationwide analysis of carotid endarterectomy over 9 years with a sample size of 229,304 patients is the largest published study on the development of the surgical treatment of carotid artery stenosis. Participation in the mandatory documentation was introduced by legislation; thus, the reported results fully represent the care situation in Germany. Because the percentage of completely evaluable data sets was continuously >98%, the data are to a large extent representative for the outcome of CEA in Germany. Only the international VASCUNET group ([18], subcommittee of the European Society of Vascular Surgery) recorded 48,185 CEA a similarly large number of cases, but all variables were documented only for less than half of cases. However, in this study, the completeness is questionable. Perhaps not all patients with perioperative strokes were included in the survey. In the present study, the proportion of women and the median age was equal to that in the international registry study of VASCUNET group [18]. Within the survey period, the proportion of patients who were 80 years or older at the time of surgery increased significantly in the study population. Although recent studies show only a small increased risk of surgery in patients over 80 years [16], it must be kept in mind that these patients only benefit from the prophylactic nature of the operation, when they have a correspondingly long life expectancy [4]. The overall comorbidity of patients has increased over the years and the number of patients with ASA status <3 has decreased. On the one hand, this may be because accompanying diseases are more carefully documented; on the other hand, this could be caused by the increasing proportion of very old patients. The distribution of indication groups did not change significantly over the survey period, but differs significantly from the indications observed in other countries. In the VASCUNET registry, 60.1% of patients were on average symptomatic [18], while in the present collective only 34.6% of patients were symptomatic and if the emergencies from group C are included 37.4%. However, a broad range between countries is also recorded in the international registry. For example, Italy reports 31.4% of patients being symptomatic, while Denmark reports 100%. The data obtained in this study also indicate that the indication group B patients 6 Gefässchirurgie

7 Relative frequency ,355 23,502 25,629 25,570 26,087 26,961 27,546 27,170 27,484 = n 14.3% 13.8% 13.8% 13.2% 13.2% 12.7% 12.3% 12.1% 11.9% 35.0% 34.4% 33.1% 35.3% 33.9% 34.6% 34.9% 35.2% 35.0% 50.7% 51.9% 53.1% 51.5% 52.9% 52.7% 52.8% 52.7% 53.1% Absolute frequency 25,000 20,000 15,000 10, Indication groups A Indication groups B C a A B C b 17,914 21,964 24,034 24,113 24,690 25,587 26,395 26,172 27,006 =n Relative frequency % 9.3% 26.7% 7.7% 14.7% 8.7% 26.6% 7.6% 14.7% 14.0% 8.6% 25.4% 6.9% 8.8% 27.3% 6.3% 14.0% 9.3% 25.3% 6.3% 12.1% 12.8% 12.6% 13.4% 2.6% 9.6% 9.2% 9.6% 32.5% 25.8% 26.5% 25.8% 6.2% 7.3% 6.1% 6.0% % 42.3% 44.3% 43.6% 45.1% 45.2% 45.6% 45.7% 45.4% c Carotid artery surgery under special conditions 70 % symptomatic stenosis 60 % asymptomatic carotid artery stenosis without contralateral stenosis or > 70% stenosis 50 60% symptomatic stenosis 60 % asymptomatic carotid artery stenosis with contralateral stenosis or >70 % stenosis Fig. 3 8 a,b Distribution of indication groups over the survey period (indication group A: asymptomatic carotid stenosis; indication group B: symptomatic carotid stenosis, elective indication group C: carotid endarterectomy under special conditions). c Distribution of the indication groups (classified according to the populations of the quality criteria QI3 QI6) over the survey period as follows: asymptomatic carotid stenosis I (without contralateral stenosis or >70% stenosis), asymptomatic carotid stenosis II (with contralateral stenosis or >70% stenosis), symptomatic carotid stenosis II ( 70%), and symptomatic carotid stenosis II (50 69%). Gefässchirurgie

8 Median interval between neurological event and carotid endarterectomy (days) days present more often with severe symptoms. The overall proportion of emergency carotid endarterectomies has also increased, as has the proportion of patients with acute or progressive stroke within this group. The increase in the number of acute stroke patients being treated is possibly due to improving interdisciplinary cooperation between vascular surgery and neurology, or stroke units, in combination with a broader availability of imaging techniques. Thus, treatment decisions could be accelerated. From the available data, it cannot be determined whether days Fig. 4 8 Interval between the neurological event in symptomatic carotid stenosis and surgery (days). Asterisk Pearson s correlation Relative frequency % 2.0% QI 3: p < 0.001, QI4: p =0.132* Perioperative stroke or death QI3: 60 % asymptomatic carotid artery stenosis without contralateral stenosis or > 70% stenosis QI4: 60 % asymptomatic carotid artery stenosis with contralateral stenosis or >70 % stenosis Year Fig. 5 8 Quality indicator 3 (QI3, red): perioperative stroke or death in asymptomatic carotid stenosis I (without contralateral stenosis or >70% stenosis) and quality indicator 4 (QI4, black): perioperative stroke or death in asymptomatic carotid stenosis II (with contralateral stenosis or >70% stenosis) 2.1% 1.1% this trend is equally distributed between hospitals or concentrated in the (university) centers. Another important factor is the preclinical time interval. A meta-analysis of 123 studies between 1987 and 2007 showed a decrease in the preclinical period after the onset of stroke symptoms, which is recorded in hours, of 6% per year [9]. This development is certainly a key factor for the clear decrease in the interval between the neurological event and surgery to 9 days. However, it also shows that the results of large trials for the treatment of symptomatic carotid artery stenosis, which recommend early surgery [17], are highly regarded in Germany. In order to improve the results further, referring physicians and the general public must be made more aware of the warning signs (TIA, amaurosis fugax) in order to reduce the preclinical period for patients with milder symptoms. The complication rate for asymptomatic carotid artery stenosis was significantly below the guideline target.» The complication rate for asymptomatic carotid stenosis was significantly below the guideline target The rate of perioperative stroke or death was significantly reduced in patients with asymptomatic stenosis without contralateral stenosis (QI3) and in patients with 50% symptomatic stenosis (QI4/QI5). In addition, the overall disease-specific morbidity such as severe strokes (Rankin 4, 5) or death (QI8) was significantly reduced. In particular, concerning asymptomatic carotid stenosis, the decrease of the complication rate from 2.0 to 1.0% in the overall survey period was well below the guideline target of 3% [7]. In international comparison, the rate of perioperative stroke or death in this group was also low. In a Cochrane systematic review on CEA for asymptomatic stenosis, the perioperative risk for this endpoint was 2.9% [3]. The overall higher morbidity in symptomatic stenosis is expected and is also reported in international studies [17]. Only the average overall mortality of 0.9% remained constant over the survey period. Encouraging is the decrease in the rate of peripheral nerve damage and cardiovascular events in the study period in the survey group presented. The average cardiovascular morbidity of 1.6% is low, compared to the results of the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST, [1]). Limitations The evaluation of the national report provides an overview of a very large collective. However, since no individual data 8 Gefässchirurgie

9 Relative frequency Relative frequency % 4.0% QI 5/6: p<0.001* % QI8: p < 0.001* are available, a correlation of morbidity and mortality on the individual risk factors and treatment modalities cannot be made. Future efforts should include an evaluation of the raw data in cooperation with the Kommission für Qualität und Sicherheit der Deutschen Gesellschaft für Gefäßchirurgie und Gefäßmedizin Gesellschaft für operative, endovaskuläre und präventive Gefäßmedizin (DGG) and the responsible federal agency. Year Perioperative stroke or death QI8: severe stroke or death (Rankin 4-6) 1.3% Fig. 7 8 Quality indicator 8 (QI8): severe stroke (Rankin score 4 6) or death in the total population. Asterisk Cochran Armitage trend test Year Perioperative stroke or death QI5: 70 % symptomatic stenosis QI6: 50 60% symptomatic stenosis 2.3% 2.7% Fig. 6 8 Quality indicator 5 (QI5, yellow): perioperative stroke or death in symptomatic carotid stenosis I ( 70%) and quality indicator 6 (QI6, green): perioperative stroke or death in symptomatic carotid stenosis II (50 69%). Asterisk Cochran Armitage trend test Since no follow-up visits are documented, no statements can be made about long-term results not even for 30-day outcome as stated in most publications. The validity of the data is dependent on the accuracy of data acquisition of those responsible at the participating clinics. The patients are mostly pre- and postoperatively evaluated by an independent neurological department. The final documentation is, however, submitted by the operating department. As discussed in detail in the part 2 of this study, an objective neurological investigation is generally performed in every patient by extradepartmental professionals in an increasing number of cases; nevertheless, an external control of the documentation does not occur. However, sampling is performed and in the case of abnormalities a so-called structured dialogue is requested. The variables studied were subject to fundamental changes over the survey period. For example, the populations of QI changed, the age groups re-distributed, the ultrasound criteria adjusted to the criteria of the German Society for Ultrasound in Medicine (DEGUM), and several parameters were not evaluated for the entire period. This makes it more difficult to compare data over the years. Conclusion F The presented data clearly demonstrate that there has been a gradual reduction in the perioperative complication rate since the introduction of mandatory QA. F There is a trend toward eversion endarterectomy and surgery under locoregional anesthesia. F The interval between the neurological event and surgery was only 9 days in the case of symptomatic carotid stenosis, which is also very low in international comparison. F The CAS data collected since 2012 will be analyzed in subsequent studies. F In the future, inclusion of the 30-day follow-up data would be desirable. Corresponding address Prof. Dr. H.-H. Eckstein Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie, Klinikum Rechts der Isar, Technische Universität München Ismaninger Str. 22, Munich Germany hheckstein@web.de Gefässchirurgie

10 Compliance with ethical guidelines Conflict of interest. L. Deutsch, B. Haller, H. Söllner, M. Storck, and H-H. Eckstein state that there are no conflicts of interest. The accompanying manuscript does not include studies on humans or animals. References 1. Brott TG, Hobson RW 2nd, Howard G et al (2010) Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363: Chalela JA (2009) Evaluating the carotid plaque: going beyond stenosis. Cerebrovasc Dis 27(Suppl 1): Chambers BR, Donnan GA (2005) Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev CD De Rango P, Lenti M, Simonte G et al (2012) No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg 44: Weerd M de, Greving JP, Hedblad B et al (2010) Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 41: Demirel S, Attigah N, Bruijnen H et al (2012) Multicenter experience on eversion versus conventional carotid endarterectomy in symptomatic carotid artery stenosis: observations from the stent-protected angioplasty versus carotid endarterectomy (Space-1) trial. Stroke 43: Eckstein H-H, Kühnl A, Berkefeld J et al (2012) S3- Leitlinie zur Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose. Gefässchirurgie 17(6) 8. Eckstein HH, Heider P, Wolf O et al (2004) Controversies in the treatment of carotid stenoses. Present state of research and evidence-based medicine. Chirurg 75: Evenson KR, Foraker RE, Morris DL, Rosamond WD (2009) A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke 4: Goldstein LB, Adams R, Alberts MJ et al (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113:e873 e Hill AB (1998) Should patients be screened for asymptomatic carotid artery stenosis? Can J Surg 41: Kolominsky-Rabas PL, Heuschmann PU, Marschall D et al (2006) Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 37: Liapis CD, Bell PR, Mikhailidis D et al (2009) ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 37: Lindsay P, Bayley M, McDonald A et al (2008) Toward a more effective approach to stroke: Canadian best practice recommendations for stroke care. CMAJ 178: Lopez AD, Mathers CD, Ezzati M et al (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: Miller MT, Comerota AJ, Tzilinis A et al (2005) Carotid endarterectomy in octogenarians: does increased age indicate high risk?. J Vasc Surg 41: Rothwell PM, Eliasziw M, Gutnikov SA et al (2003) Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361: Vikatmaa P, Mitchell D, Jensen LP et al (2012) Variation in clinical practice in carotid surgery in nine countries Lessons from VAS- CUNET and recommendations for the future of national clinical audit. Eur J Vasc Endovasc Surg 44: Gefässchirurgie

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

3. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose, AWMF-Registernummer ,

3. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der extracraniellen Carotisstenose, AWMF-Registernummer , Literaturverzeichnis zum Titelthema S3-Leitlinie Extrakranielle Karotisstenose. Multidisziplinäre, evidenzund konsensbasierte deutsch-österreichische Leitlinie Bayerisches Ärzteblatt 3/2015, Seite 72 ff.

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

Carotid Artery Stenosis

Carotid Artery Stenosis Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

Advances in the treatment of posterior cerebral circulation symptomatic disease

Advances in the treatment of posterior cerebral circulation symptomatic disease Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #344: Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Effective Clinical

More information

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no

More information

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease

More information

LARGE ARTERY DISEASE pathophysiology of ischemic insults. ISCHEMIC STROKE & TIA main etiologies

LARGE ARTERY DISEASE pathophysiology of ischemic insults. ISCHEMIC STROKE & TIA main etiologies תאריך בדיקה- 27.1.04 דופלקס עורקי צוואר - משמעות בגיל הקשיש דר' יונתן שטרייפלר מנהל היחידה הנוירולוגית מרכז רפואי רבין - בי"ח השרון ISCHEMIC STROKE & TIA main etiologies Large vessel (artery) disease -

More information

ISCHEMIC STROKE & TIA main etiologies

ISCHEMIC STROKE & TIA main etiologies דופלקס עורקי צוואר - משמעות בגיל הקשיש דר' יונתן שטרייפלר מנהל היחידה הנוירולוגית מרכז רפואי רבין - בי"ח השרון תאריך בדיקה- 27.1.04 ISCHEMIC STROKE & TIA main etiologies Large vessel (artery) disease -

More information

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation

More information

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital CAROTID STENTING A 2009 UPDATE Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital TREATMENT FOR CAROTID STENOSIS Best medical management Antiplatelet therapy Antihypertensive

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Epidemiology and inpatient treatment of vascular diseases in Germany

Epidemiology and inpatient treatment of vascular diseases in Germany Originalien Gefässchirurgie 216 [Suppl 1]: 21:S14 S23 DOI 1.17/s772-15-95-5 Published online: 23 October 215 The Author(s) 215. This article is published with open access at Springerlink.com A. Kühnl H.

More information

Carotid Artery Stenting Versus

Carotid Artery Stenting Versus Carotid Artery Stenting Versus Carotid Endarterectomy Seong-Wook Park, MD, PhD, FACC,, Seoul, Korea Stroke & Carotid artery stenosis Stroke & Carotid artery stenosis Cerebrovascular disease is one of the

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

Guidelines for Ultrasound Surveillance

Guidelines for Ultrasound Surveillance Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund The Great Swedish Debate Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund My Disclosures Trying to bribe the moderators What do my patients expect? Balanced information

More information

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS Assistant Professor of Surgery Director of Carotid Interventions Division of Vascular & Endovascular Surgery Stony Brook University

More information

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany MEET Θ 2006 Why I stent asymptomatic and symptomatic patients K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany Evidence for treating symptomatic patients symptomatic patients

More information

ESC Heart & Brain Workshop

ESC Heart & Brain Workshop ESC Heart & Brain Workshop The role of vascular surgeon in stroke prevention Barbara Rantner, MD, PhD, Department of Vascular Surgery, Medical University Innsbruck, Innsbruck, Austria Supported by Bayer,

More information

MEDICINE. Methods Stroke database Hesse ORIGINAL ARTICLE

MEDICINE. Methods Stroke database Hesse ORIGINAL ARTICLE ORIGINAL ARTICLE The Projected Burden of Stroke in the German Federal State of Hesse Up to the Year 2050 Christian Foerch, Bjoern Misselwitz, Matthias Sitzer, Helmuth Steinmetz, Tobias Neumann-Haefelin

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Fast-track CEA: a 3-year experience

Fast-track CEA: a 3-year experience Fast-track CEA: a 3-year experience Giorgio L. Poletto, MD Milano, Italy 6th ACST-2 Collaborators Meeting, Palau de Congresos, Valencia. 24th and 25th September 2018. Stroke prevention Primary prevention:

More information

Alma Mater Studiorum Università di Bologna

Alma Mater Studiorum Università di Bologna Alma Mater Studiorum Università di Bologna S.Orsola-Malpighi, Bologna, Italia Chirurgia Vascolare The volume of cerebral ischaemic lesion predicts the outcome after symptomatic carotid revascularisation

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data

The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data Schindler A 1, Bonati LH 2, Schinner R 1, Altaf N 3, Hosseini AA 3, Esposito-Bauer

More information

AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS

AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS Pak Heart J ORIGINAL ARTICLE AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS 1 2 3 4 5 Abhishek Nemani, Arshad Ali, Arshad Rehan, Ali Aboufaris, Jabar Ali 1-4 Guthrie

More information

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) T-Woei Tan, MD, FACS, RPVI Assistant Professor of Surgery Vascular and Endovascular Surgery Louisiana State University Health -

More information

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b

More information

Tips and Tricks for CAS T-CAR

Tips and Tricks for CAS T-CAR Tips and Tricks for CAS T-CAR H.-H. Eckstein, M. Kallmayer Department for Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich,, Germany Disclosures Collaborator

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention Christopher J. White MD, MSCAI Chief of Medical Services, Professor and Chairman of Medicine Ochsner Medical Center

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #345 (NQF 1543): Rate of Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) Who Are Stroke Free or Discharged Alive National Quality Strategy Domain: Effective Clinical Care 2018

More information

Michael Horowitz, MD Pittsburgh, PA

Michael Horowitz, MD Pittsburgh, PA Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion

More information

Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed Surgery?

Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed Surgery? Eur J Vasc Endovasc Surg 30, 36 40 (2005) doi:10.1016/j.ejvs.2005.02.045, available online at http://www.sciencedirect.com on Carotid Endarterectomy after Ischemic Stroke Is there a Justification for Delayed

More information

Accumulating evidence from randomized, controlled trials shows that carotid. Efficacy versus Effectiveness of Carotid Endarterectomy

Accumulating evidence from randomized, controlled trials shows that carotid. Efficacy versus Effectiveness of Carotid Endarterectomy BACK OF THE ENVELOPE DAVID A. GOULD, MD Research Fellow VA Outcomes Group Department of Veterans Affairs Medical Center White River Junction, Vt Resident Department of Dartmouth Medical School Hanover,

More information

Will guidelines and clinical practice for asymptomatic stenosis change in the near future?

Will guidelines and clinical practice for asymptomatic stenosis change in the near future? Will guidelines and clinical practice for asymptomatic stenosis change in the near future? M Storck, MD, PhD Director Dept. Vascular and Thoracic Surgery Klinikum Karlsruhe Academic Teaching Hospital,

More information

Emboli detection to evaluate risk of stroke

Emboli detection to evaluate risk of stroke Emboli detection to evaluate risk of stroke Background: Improved methods are required to identify patients with asymptomatic carotid stenosis at high risk for stroke. Whether surgery is beneficial for

More information

Peripheral Vascular Disease

Peripheral Vascular Disease Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of

More information

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea R. Pini, G.L. Faggioli, M. Gargiulo, E. Pisano, A. Pilato, E. Gallitto, C. Mascoli, L.M. Cacioppa, A. Vacirca,

More information

More than strokes occur

More than strokes occur Surgery vs Stent: Treatment for Carotid Artery Disease Imad A. Alhaddad, MD ABSTRACT PURPOSE: This article summarizes and compares the roles of surgery and stent in the management of carotid artery disease.

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

Management of transient ischemic attack or nondisabling stroke related to extracranial internal carotid artery stenosis

Management of transient ischemic attack or nondisabling stroke related to extracranial internal carotid artery stenosis CPD Management of transient ischemic attack or nondisabling stroke related to extracranial internal carotid artery stenosis Varun Kapila MD, Prasad Jetty MD MSc, Vincenzo S. Basile MD BEd, Luc Dubois MD

More information

Clinical experience amongst surgeons in the Asymptomatic Carotid Surgery Trial-1 (ACST-1)

Clinical experience amongst surgeons in the Asymptomatic Carotid Surgery Trial-1 (ACST-1) Clinical experience amongst surgeons in the Asymptomatic Carotid Surgery Trial-1 (ACST-1) Short Title: Clinical experience in the Asymptomatic Carotid Surgery Trial-1 (ACST-1) Authors: Anne Huibers 1,2,

More information

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Assessment of the procedural etiology of stroke resulting from carotid artery stenting Assessment of the procedural etiology of stroke resulting from carotid artery stenting 1. Study Purpose and Rationale: A. Background Stroke is the 3 rd leading cause of death in the United States and carries

More information

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease GJ de Borst Department of Vascular Surgery RECOMMENDATION GRADING CRITERIA What is new

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

SAMIR R. KAPADIA, MD Department of Cardiovascular Medicine, Cleveland Clinic

SAMIR R. KAPADIA, MD Department of Cardiovascular Medicine, Cleveland Clinic INTERPRETING KEY TRIALS CME CREDIT EDUCATIONAL OBJECTIVE: Readers will discuss the risks and benefits of carotid artery stenting vs endarterectomy with prospective candidates for these procedures OLCAY

More information

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The

More information

How Duplex Ultrasound Screening Can Lead to Overuse of Carotid Interventions. No Disclosures. Prevalence >70% Asymptomatic ICA Stenosis*

How Duplex Ultrasound Screening Can Lead to Overuse of Carotid Interventions. No Disclosures. Prevalence >70% Asymptomatic ICA Stenosis* How Duplex Ultrasound Screening Can Lead to Overuse of Carotid Interventions Gregory L. Moneta, M.D. Chief, Division of Vascular Surgery Department of Surgery Knight Cardiovascular Institute Oregon Health

More information

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press) Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN 0140-6736 (In Press) Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/1087/1/lancet_clots_1_20090522_4.pdf

More information

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Tarvinder Singh, MS, MD Neurohospitalist Swedish Neuroscience Institute 1 Objectives Definition Why the urgency? Evidence/Guidelines

More information

The Diagnosis, Treatment and Follow-up of Extracranial Carotid Stenosis A Multidisciplinary German-Austrian Guideline Based on Evidence and Consensus

The Diagnosis, Treatment and Follow-up of Extracranial Carotid Stenosis A Multidisciplinary German-Austrian Guideline Based on Evidence and Consensus CLINICAL PRACTICE GUIDELINE The Diagnosis, Treatment and Follow-up of Extracranial Carotid Stenosis A Multidisciplinary German-Austrian Guideline Based on Evidence and Consensus Hans-Henning Eckstein,

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians 6.3 Early carotid imaging in acute stroke or TIA Evidence Tables IMAG4: Which patients with suspected stroke/tia should be referred for urgent carotid imaging? Reference Ahmed AS, Foley E, Brannigan AE

More information

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Open heart surgery or carotid endarterectomy. Which procedure should be done first? Open heart surgery or carotid endarterectomy. Which procedure should be done first? Pedro Pinto Sousa 1, Gabriela Teixeira 2, João Gonçalves 2 ; Luís Vouga 1, Rui Almeida 2 ; Pedro Sá Pinto 2 1 Centro

More information

International Journal of Stroke

International Journal of Stroke 10-year risk of stroke in patients with previous cerebral infarction and the impact of carotid surgery in the Asymptomatic Carotid Surgery Trial (ACST-1) Journal: International Journal of Stroke Manuscript

More information

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH

More information

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting Employment

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Endovascular Therapies for Extracranial Vertebral Artery Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endovascular_therapies_for_extracranial_vertebral_artery_disease

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA

Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA SUNY DOWNSTATE MEDICAL CENTER Case 61 year old male referred to Vascular Surgery for left internal carotid stenosis Presented with transient

More information

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate

More information

Risk of Early Carotid Endarterectomy for Symptomatic Carotid Stenosis

Risk of Early Carotid Endarterectomy for Symptomatic Carotid Stenosis Risk of Early Carotid Endarterectomy for Carotid Stenosis Waleed Brinjikji, BS; Alejandro A. Rabinstein, MD; Fredric B. Meyer, MD; David G. Piepgras, MD; Giuseppe Lanzino, MD Background and Purpose The

More information

Luisa Vinciguerra. Ictus recidivanti

Luisa Vinciguerra. Ictus recidivanti Luisa Vinciguerra Ictus recidivanti Recurrent Strokes DEFINITION Population-based studies exclude strokes: - within 28 or 21 days of the incident event - events in the same vascular territory as the original

More information

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading

More information

Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2

Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2 Update on the only remaining Carotid Multicenter Randomised International Trial in the World:ACST-2 Alison Halliday MD Professor of Vascular Surgery University of Oxford Disclosure Statement of Financial

More information

Carotid Artery Stenting Today: A Few Updating Remarks

Carotid Artery Stenting Today: A Few Updating Remarks Carotid Artery Stenting Today: A Few Updating Remarks Camilo R. Gomez, MD, MBA Director, Alabama Neurological Institute Birmingham, Alabama Disclaimer & Warning Company Pharmaceutical BMS-Sanofi-Aventis

More information

Early versus delayed carotid endarterectomy in symptomatic patients

Early versus delayed carotid endarterectomy in symptomatic patients From the Southern Association for Vascular Surgery Early versus delayed carotid endarterectomy in symptomatic patients Suman Annambhotla, MD, Michael S. Park, MD, Mark L. Keldahl, MD, Mark D. Morasch,

More information

Very Urgent Carotid Endarterectomy Confers Increased Procedural Risk

Very Urgent Carotid Endarterectomy Confers Increased Procedural Risk Very Urgent Carotid Endarterectomy Confers Increased Procedural Risk Sofia Strömberg, MD; Johan Gelin, MD, PhD; Torun Österberg, PhD; Göran M.L. Bergström, MD, PhD; Lars Karlström, MD, PhD; Klas Österberg,

More information

TITLE: Carotid Artery Stenting versus Carotid Endarterectomy: A Review of the Clinical and Cost-Effectiveness

TITLE: Carotid Artery Stenting versus Carotid Endarterectomy: A Review of the Clinical and Cost-Effectiveness TITLE: Carotid Artery Stenting versus Carotid Endarterectomy: A Review of the Clinical and Cost-Effectiveness DATE: 22 September 2009 CONTEXT AND POLICY ISSUES: A stroke is an interruption of blood supply

More information

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015

Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015 Carotid Artery Surgery for the Prevention and Treatment of Ischemic Stroke Update 2015 John L. Crawford, MD, FACS Neuroscience Summit 2015 UNT Health Sciences Center September 12, 2015 www.cdc.gov/datastatistics2013

More information

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the

More information

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ

Stroke prevention in asymptomatic carotid stenosis. ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Stroke prevention in asymptomatic carotid stenosis ΛΙΛΛΗΣ ΛΕΩΝΙΔΑΣ Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογικής Κλινικής ΑΠΘ ΠΓΝΘ ΑΧΕΠΑ Σεμινάρια Ομάδων Εργασίας Ελληνικής Καρδιολογικής Εταιρείας

More information

CLINICAL TRIAL PROTOCOL SPACE 2. Stent-protected Angioplasty. in Asymptomatic Carotid Artery Stenosis. vs. Endarterectomy. Two two-arm Clinical Trials

CLINICAL TRIAL PROTOCOL SPACE 2. Stent-protected Angioplasty. in Asymptomatic Carotid Artery Stenosis. vs. Endarterectomy. Two two-arm Clinical Trials CLINICAL TRIAL PROTOCOL SPACE 2 Stent-protected Angioplasty in Asymptomatic Carotid Artery Stenosis vs. Endarterectomy Two two-arm Clinical Trials Clinical Trial Code: SPACE 2 ISRCTN number: ISRCTN 78592017

More information

Surgical Procedures for. Symptomatic Post-CAS Carotid. Restenosis: Experiences and. Mid-Term Outcomes. Lefeng Qu M.D., Ph.D. Professor of Surgery

Surgical Procedures for. Symptomatic Post-CAS Carotid. Restenosis: Experiences and. Mid-Term Outcomes. Lefeng Qu M.D., Ph.D. Professor of Surgery Surgical Procedures for Symptomatic Post-CAS Carotid Restenosis: Experiences and Mid-Term Outcomes Lefeng Qu M.D., Ph.D. Professor of Surgery Department of Vascular and Endovascular Surgery, Changzheng

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry

Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry Björn Kragsterman, MD, a Håkan ärsson, MD, hd, a Johan Lindbäck, MSc, b David

More information

Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years

Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years Carotid endarterectomy to correct asymptomatic carotid stenosis: Ten years later David Rosenthal, M.D., Randal Rudderman, M.D., Edgar Borrero, M.D., David H. Hafner, M.D., Garland D. Perdue, M.D., Pano

More information

Carotid. The. Issue. Now approved by the FDA, carotid stenting moves into the spotlight in endovascular care.

Carotid. The. Issue. Now approved by the FDA, carotid stenting moves into the spotlight in endovascular care. The Carotid Issue 33 Carotid Revascularization in 2004 By Thomas G. Brott, MD; Jamie Roberts, LPN, CRC; Robert W. Hobson II, MD; and Susan Hughes, BSN Now approved by the FDA, carotid stenting moves into

More information

Internal carotid artery near-total occlusions: Is it justified to operate on them?

Internal carotid artery near-total occlusions: Is it justified to operate on them? Internal carotid artery near-total occlusions: Is it justified to operate on them? Christos D. Liapis Professor (Em) of Vascular Surgery Athens University Medical School Director Vascular & Endovascular

More information

CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS

CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Management of Extracranial Carotid Disease and Intracranial Atherosclerosis Wein T, Gladstone D (Writing Group Chairs) on Behalf of the PREVENTION of STROKE

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and

More information

Mohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD*

Mohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD* Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Mohamed Al-Khaled,

More information

Impact of the Aortic Arch on Stent Performance

Impact of the Aortic Arch on Stent Performance Impact of the Aortic Arch on Stent Performance GianLuca Faggioli Vascular Surgery Alma Mater Studiorum UniversitY of Bologna ACST-2 Indications for carotid stenting: a preview of the potential derived

More information

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific Stenting carotideo nel paziente sintomatico alla luce dei nuovi trials Savona, 11 Aprile 2015 Gioel GabrioSecco, MD, PhD Emodinamica e CardiologiaInterventistica Ospedale SantiAntonio e Biagio e Cesare

More information

Thrombectomy with the preset stent-retriever. Insights from the ARTESp* trial

Thrombectomy with the preset stent-retriever. Insights from the ARTESp* trial Thrombectomy with the preset stent-retriever Insights from the ARTESp* trial Wiebke Kurre, MD Klinikum Stuttgart - Germany * Acute Recanalization of Thrombo-Embolic Ischemic Stroke with preset (ARTESp)

More information